According to TherapeuticsMD's latest financial reports the company's total debt is $7.8 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-12-31 | $8.75 M | -95.57% |
2021-12-31 | $0.19 B | -20.49% |
2020-12-31 | $0.24 B | 21.12% |
2019-12-31 | $0.20 B | 179.75% |
2018-12-31 | $73.38 M | |
2012-12-31 | $3.58 M | 52.73% |
2011-12-31 | $2.35 M | 211.87% |
2010-12-31 | $0.75 M | 25.59% |
2009-12-31 | $0.6 M | |
2005-12-31 | $0.08 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $68.70 B | 880,545.99% | ๐บ๐ธ USA |
AbbVie ABBV | $74.00 B | 948,387.57% | ๐บ๐ธ USA |
Agile Therapeutics
AGRX | $0.37 M | -95.16% | ๐บ๐ธ USA |
Royalty Pharma RPRX | $6.13 B | 78,589.82% | ๐ฌ๐ง UK |
Lannett Company LCI | $0.63 B | 8,098.26% | ๐บ๐ธ USA |